Cargando…

Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGE

BACKGROUND: Cancer arises from normal cells through the stepwise accumulation of genetic alterations. Cancer development can be studied by direct genetic manipulation within experimental models of tumorigenesis. Thereby, confusion by the genetic heterogeneity of patients can be circumvented. Moreove...

Descripción completa

Detalles Bibliográficos
Autores principales: Pütz, Stephanie M, Vogiatzi, Fotini, Stiewe, Thorsten, Sickmann, Albert
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955615/
https://www.ncbi.nlm.nih.gov/pubmed/20860785
http://dx.doi.org/10.1186/1476-4598-9-254
_version_ 1782188052252196864
author Pütz, Stephanie M
Vogiatzi, Fotini
Stiewe, Thorsten
Sickmann, Albert
author_facet Pütz, Stephanie M
Vogiatzi, Fotini
Stiewe, Thorsten
Sickmann, Albert
author_sort Pütz, Stephanie M
collection PubMed
description BACKGROUND: Cancer arises from normal cells through the stepwise accumulation of genetic alterations. Cancer development can be studied by direct genetic manipulation within experimental models of tumorigenesis. Thereby, confusion by the genetic heterogeneity of patients can be circumvented. Moreover, identification of the critical changes that convert a pre-malignant cell into a metastatic, therapy resistant tumor cell, however, is one necessary step to develop effective and selective anti-cancer drugs. Thus, for the current study a cell culture model for malignant transformation was used: Primary human fibroblasts of the BJ strain were sequentially transduced with retroviral vectors encoding the genes for hTERT (cell line BJ-T), simian virus 40 early region (SV40 ER, cell line BJ-TE) and H-Ras V12 (cell line BJ-TER). RESULTS: The stepwise malignant transformation of human fibroblasts was analyzed on the protein level by differential proteome analysis. We observed 39 regulated protein spots and therein identified 67 different proteins. The strongest change of spot patterns was detected due to integration of SV40 ER. Among the proteins being significantly regulated during the malignant transformation process well known proliferating cell nuclear antigen (PCNA) as well as the chaperones mitochondrial heat shock protein 75 kDa (TRAP-1) and heat shock protein HSP90 were identified. Moreover, we find out, that TRAP-1 is already up-regulated by means of SV40 ER expression instead of H-Ras V12. Furthermore Peroxiredoxin-6 (PRDX6), Annexin A2 (p36), Plasminogen activator inhibitor 2 (PAI-2) and Keratin type II cytoskeletal 7 (CK-7) were identified to be regulated. For some protein candidates we confirmed our 2D-PAGE results by Western Blot. CONCLUSION: These findings give further hints for intriguing interactions between the p16-RB pathway, the mitochondrial chaperone network and the cytoskeleton. In summary, using a cell culture model for malignant transformation analyzed with 2D-PAGE, proteome and cellular changes can be related to defined steps of tumorigenesis.
format Text
id pubmed-2955615
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29556152010-10-16 Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGE Pütz, Stephanie M Vogiatzi, Fotini Stiewe, Thorsten Sickmann, Albert Mol Cancer Research BACKGROUND: Cancer arises from normal cells through the stepwise accumulation of genetic alterations. Cancer development can be studied by direct genetic manipulation within experimental models of tumorigenesis. Thereby, confusion by the genetic heterogeneity of patients can be circumvented. Moreover, identification of the critical changes that convert a pre-malignant cell into a metastatic, therapy resistant tumor cell, however, is one necessary step to develop effective and selective anti-cancer drugs. Thus, for the current study a cell culture model for malignant transformation was used: Primary human fibroblasts of the BJ strain were sequentially transduced with retroviral vectors encoding the genes for hTERT (cell line BJ-T), simian virus 40 early region (SV40 ER, cell line BJ-TE) and H-Ras V12 (cell line BJ-TER). RESULTS: The stepwise malignant transformation of human fibroblasts was analyzed on the protein level by differential proteome analysis. We observed 39 regulated protein spots and therein identified 67 different proteins. The strongest change of spot patterns was detected due to integration of SV40 ER. Among the proteins being significantly regulated during the malignant transformation process well known proliferating cell nuclear antigen (PCNA) as well as the chaperones mitochondrial heat shock protein 75 kDa (TRAP-1) and heat shock protein HSP90 were identified. Moreover, we find out, that TRAP-1 is already up-regulated by means of SV40 ER expression instead of H-Ras V12. Furthermore Peroxiredoxin-6 (PRDX6), Annexin A2 (p36), Plasminogen activator inhibitor 2 (PAI-2) and Keratin type II cytoskeletal 7 (CK-7) were identified to be regulated. For some protein candidates we confirmed our 2D-PAGE results by Western Blot. CONCLUSION: These findings give further hints for intriguing interactions between the p16-RB pathway, the mitochondrial chaperone network and the cytoskeleton. In summary, using a cell culture model for malignant transformation analyzed with 2D-PAGE, proteome and cellular changes can be related to defined steps of tumorigenesis. BioMed Central 2010-09-22 /pmc/articles/PMC2955615/ /pubmed/20860785 http://dx.doi.org/10.1186/1476-4598-9-254 Text en Copyright ©2010 Pütz et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Pütz, Stephanie M
Vogiatzi, Fotini
Stiewe, Thorsten
Sickmann, Albert
Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGE
title Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGE
title_full Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGE
title_fullStr Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGE
title_full_unstemmed Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGE
title_short Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGE
title_sort malignant transformation in a defined genetic background: proteome changes displayed by 2d-page
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955615/
https://www.ncbi.nlm.nih.gov/pubmed/20860785
http://dx.doi.org/10.1186/1476-4598-9-254
work_keys_str_mv AT putzstephaniem malignanttransformationinadefinedgeneticbackgroundproteomechangesdisplayedby2dpage
AT vogiatzifotini malignanttransformationinadefinedgeneticbackgroundproteomechangesdisplayedby2dpage
AT stiewethorsten malignanttransformationinadefinedgeneticbackgroundproteomechangesdisplayedby2dpage
AT sickmannalbert malignanttransformationinadefinedgeneticbackgroundproteomechangesdisplayedby2dpage